Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Dose-Ranging, Double Blind Study of Lidocaine Hydrochloride and/or Hydrocortisone Acetate (Alone or in Combination) in the 14-Day Twice-Daily Treatment of Grade I or II Hemorrhoids

NCT02689856 is registered in ClinicalTrials.gov with Citius Pharmaceuticals, Inc. as lead sponsor.

NCT NCT02689856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02689856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Dose-Ranging, Double Blind Study of Lidocaine Hydrochloride and/or Hydrocortisone Acetate (Alone or in Combination) in the 14-Day Twice-Daily Treatment of Grade I or II Hemorrhoids
Lead sponsor
Citius Pharmaceuticals, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2015
Completion date
October 31, 2015
Enrollment
211 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemorrhoids